Walleye Trading’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.33M Sell
18,200
-3,300
-15% -$1.08M 0.01% 1107
2025
Q4
$7.54M Sell
21,500
-4,600
-18% -$1.55M 0.01% 1067
2025
Q3
$8.43M Sell
26,100
-2,200
-8% -$684K 0.01% 981
2025
Q2
$11M Buy
28,300
+10,200
+56% +$4.1M 0.02% 767
2025
Q1
$7.87M Buy
18,100
+10,100
+126% +$4.05M 0.02% 857
2024
Q4
$2.95M Sell
8,000
-19,600
-71% -$8.2M 0.01% 1471
2024
Q3
$14.4M Buy
27,600
+17,800
+182% +$9.51M 0.03% 596
2024
Q2
$5.31M Buy
9,800
+7,700
+367% +$4.07M 0.01% 1026
2024
Q1
$1.09M Sell
2,100
-1,200
-36% -$597K ﹤0.01% 2171
2023
Q4
$1.56M Sell
3,300
-4,700
-59% -$2.17M ﹤0.01% 2120
2023
Q3
$3.48M Sell
8,000
-29,100
-78% -$13.2M 0.01% 1363
2023
Q2
$16.5M Buy
37,100
+24,200
+188% +$11.2M 0.05% 364
2023
Q1
$5.93M Sell
12,900
-1,300
-9% -$619K 0.01% 925
2022
Q4
$7.28M Sell
14,200
-2,700
-16% -$1.37M 0.02% 843
2022
Q3
$7.68M Sell
16,900
-2,800
-14% -$1.34M 0.02% 761
2022
Q2
$9.51M Buy
19,700
+18,500
+1,542% +$9.15M 0.03% 643
2022
Q1
$589K Sell
1,200
-9,200
-88% -$4.21M ﹤0.01% 2731
2021
Q4
$4.82M Sell
10,400
-18,600
-64% -$7.83M 0.02% 1006
2021
Q3
$10.8M Buy
29,000
+21,900
+308% +$8.32M 0.04% 513
2021
Q2
$2.71M Sell
7,100
-2,200
-24% -$841K 0.01% 1242
2021
Q1
$3.34M Sell
9,300
-16,700
-64% -$5.37M 0.01% 930
2020
Q4
$8.35M Buy
26,000
+14,200
+120% +$4.36M 0.04% 472
2020
Q3
$3.17M Sell
11,800
-19,700
-63% -$5.3M 0.02% 829
2020
Q2
$8.28M Buy
31,500
+5,200
+20% +$1.39M 0.05% 339
2020
Q1
$5.97M Buy
26,300
+6,100
+30% +$1.66M 0.05% 335
2019
Q4
$6.1M Buy
20,200
+5,500
+37% +$1.51M 0.04% 473
2019
Q3
$3.53M Buy
14,700
+400
+3% +$110K 0.03% 656
2019
Q2
$4.04M Sell
14,300
-3,100
-18% -$847K 0.03% 585
2019
Q1
$4.99M Buy
17,400
+3,300
+23% +$954K 0.04% 492
2018
Q4
$3.7M Sell
14,100
-10,500
-43% -$2.89M 0.03% 641
2018
Q3
$6.74M Sell
24,600
-7,000
-22% -$1.82M 0.04% 495
2018
Q2
$7.52M Sell
31,600
-2,900
-8% -$672K 0.04% 402
2018
Q1
$7.58M Buy
34,500
+30,100
+684% +$7.07M 0.04% 351
2017
Q4
$995 Sell
4,400
-43,800
-91% -$9.33M ﹤0.01% 1953
2017
Q3
$9.15K Sell
48,200
-8,900
-16% -$1.69M 0.05% 352
2017
Q2
$10.7K Buy
57,100
+55,500
+3,469% +$9.97M 0.07% 264
2017
Q1
$266 Buy
1,600
+100
+7% +$15.9K ﹤0.01% 2723
2016
Q4
$216K Sell
1,500
-2,100
-58% -$281K ﹤0.01% 2741
2016
Q3
$455K Sell
3,600
-36,500
-91% -$4.71M ﹤0.01% 2199
2016
Q2
$5.27M Buy
40,100
+17,400
+77% +$2.38M 0.03% 423
2016
Q1
$3.16M Sell
22,700
-48,800
-68% -$6.52M 0.03% 590
2015
Q4
$9.97M Sell
71,500
-17,100
-19% -$2.36M 0.1% 195
2015
Q3
$12.4M Buy
88,600
+82,200
+1,284% +$12.4M 0.11% 131
2015
Q2
$1.05M Buy
6,400
+3,600
+129% +$575K 0.01% 1093
2015
Q1
$430K Sell
2,800
-19,000
-87% -$2.71M ﹤0.01% 1603
2014
Q4
$2.74M Buy
21,800
+8,200
+60% +$1.01M 0.02% 542
2014
Q3
$1.63M Buy
13,600
+11,300
+491% +$1.3M 0.02% 553
2014
Q2
$248 Buy
2,300
+1,800
+360% +$185K ﹤0.01% 1823
2014
Q1
$50 Buy
500
+100
+25% +$9.04K ﹤0.01% 2711
2013
Q4
$37K Sell
400
-2,400
-86% -$213K ﹤0.01% 2944
2013
Q3
$234K Sell
2,800
-9,500
-77% -$814K ﹤0.01% 1620
2013
Q2
$1M Buy
+12,300
New +$921K 0.01% 883

Other funds holding ELV

Walleye Trading's ELV Position: Q1 2026 in Review

Walleye Trading increased its Elevance Health (ELV) stake by 8% in Q1 2026, buying an estimated $59.8K and bringing the position to 2,457 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

Walleye Trading first reported a position in ELV in Q2 2013 and has held it in 30 quarters since. The position peaked at $11.2M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Walleye Trading held 2,457 shares of Elevance Health worth $719K as of Q1 2026.
  • Walleye Trading bought 182 Elevance Health shares in Q1 2026, an estimated $59.8K.
  • Elevance Health made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2350 holding.
  • Walleye Trading first reported a position in Elevance Health in Q2 2013 and has held it in 30 quarters since.
  • Walleye Trading's Elevance Health position peaked at $11.2M in Q4 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.